286 related articles for article (PubMed ID: 29431644)
1. Induction of microRNA-199 by Nitric Oxide in Endothelial Cells Is Required for Nitrovasodilator Resistance via Targeting of Prostaglandin I2 Synthase.
Bai YP; Zhang JX; Sun Q; Zhou JP; Luo JM; He LF; Lin XC; Zhu LP; Wu WZ; Wang ZY; Zhang GG
Circulation; 2018 Jul; 138(4):397-411. PubMed ID: 29431644
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Aberrant MicroRNA-133a Expression in Endothelial Cells by Statin Prevents Endothelial Dysfunction by Targeting GTP Cyclohydrolase 1 in Vivo.
Li P; Yin YL; Guo T; Sun XY; Ma H; Zhu ML; Zhao FR; Xu P; Chen Y; Wan GR; Jiang F; Peng QS; Liu C; Liu LY; Wang SX
Circulation; 2016 Nov; 134(22):1752-1765. PubMed ID: 27765794
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium.
Joris V; Gomez EL; Menchi L; Lobysheva I; Di Mauro V; Esfahani H; Condorelli G; Balligand JL; Catalucci D; Dessy C
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2345-2357. PubMed ID: 29976767
[TBL] [Abstract][Full Text] [Related]
4. S-Nitrosylation of Prostacyclin Synthase Instigates Nitrate Cross-Tolerance In Vivo.
Zhou SN; Lu JX; Wang XQ; Shan MR; Miao Z; Pan GP; Jian X; Li P; Ping S; Pang XY; Bai YP; Liu C; Wang SX
Clin Pharmacol Ther; 2019 Jan; 105(1):201-209. PubMed ID: 29672839
[TBL] [Abstract][Full Text] [Related]
5. Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase.
Sun HX; Zeng DY; Li RT; Pang RP; Yang H; Hu YL; Zhang Q; Jiang Y; Huang LY; Tang YB; Yan GJ; Zhou JG
Hypertension; 2012 Dec; 60(6):1407-14. PubMed ID: 23108656
[TBL] [Abstract][Full Text] [Related]
6. P66Shc-Induced MicroRNA-34a Causes Diabetic Endothelial Dysfunction by Downregulating Sirtuin1.
Li Q; Kim YR; Vikram A; Kumar S; Kassan M; Gabani M; Lee SK; Jacobs JS; Irani K
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2394-2403. PubMed ID: 27789474
[TBL] [Abstract][Full Text] [Related]
7. Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide.
Skogastierna C; Luksha L; Kublickiene K; Eliasson E; Rane A; Ekström L
Heart Vessels; 2011 Nov; 26(6):628-36. PubMed ID: 21213109
[TBL] [Abstract][Full Text] [Related]
8. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment.
Schulz E; Tsilimingas N; Rinze R; Reiter B; Wendt M; Oelze M; Woelken-Weckmüller S; Walter U; Reichenspurner H; Meinertz T; Münzel T
Circulation; 2002 Mar; 105(10):1170-5. PubMed ID: 11889009
[TBL] [Abstract][Full Text] [Related]
9. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta.
Mülsch A; Oelze M; Klöss S; Mollnau H; Töpfer A; Smolenski A; Walter U; Stasch JP; Warnholtz A; Hink U; Meinertz T; Münzel T
Circulation; 2001 May; 103(17):2188-94. PubMed ID: 11331261
[TBL] [Abstract][Full Text] [Related]
10. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase.
Brandes RP; Kim D; Schmitz-Winnenthal FH; Amidi M; Gödecke A; Mülsch A; Busse R
Hypertension; 2000 Jan; 35(1 Pt 2):231-6. PubMed ID: 10642303
[TBL] [Abstract][Full Text] [Related]
11. Rumex acetosa L. induces vasorelaxation in rat aorta via activation of PI3-kinase/Akt- AND Ca(2+)-eNOS-NO signaling in endothelial cells.
Sun YY; Su XH; Jin JY; Zhou ZQ; Sun SS; Wen JF; Kang DG; Lee HS; Cho KW; Jin SN
J Physiol Pharmacol; 2015 Dec; 66(6):907-15. PubMed ID: 26769840
[TBL] [Abstract][Full Text] [Related]
12. The new organic nitrate 2-nitrate-1,3-diocthanoxypropan (NDOP) induces nitric oxide production and vasorelaxation via activation of inward-rectifier potassium channels (K
Bernardino-Paula R; Carvalho-Galvão A; Cavalcanti ALM; Rocha PKL; Carvalho LRRA; Brandão MCR; Athayde-Filho PF; Diniz TF; Lemos VS; França-Silva MS; Montenegro MF; Weitzberg E; Lundberg JO; Carlström M; Braga VA
Nitric Oxide; 2020 Nov; 104-105():61-69. PubMed ID: 33038483
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nitrovasodilator- and acetylcholine-induced relaxation and cyclic GMP accumulation by the cytochrome P-450 substrate, 7-ethoxyresorufin.
Bennett BM; McDonald BJ; Nigam R; Long PG; Simon WC
Can J Physiol Pharmacol; 1992 Sep; 70(9):1297-303. PubMed ID: 1362924
[TBL] [Abstract][Full Text] [Related]
14. Endothelial NO Production Is Mandatory for Epigallocatechin-3-Gallate-induced Vasodilation: Results From eNOS Knockout (eNOS-/-) Mice.
Lorenz M; Klinkner L; Baumann G; Stangl K; Stangl V
J Cardiovasc Pharmacol; 2015 Jun; 65(6):607-10. PubMed ID: 25714597
[TBL] [Abstract][Full Text] [Related]
15. Nitrate tolerance impairs nitric oxide-mediated vasodilation in vivo.
Laursen JB; Boesgaard S; Poulsen HE; Aldershvile J
Cardiovasc Res; 1996 May; 31(5):814-9. PubMed ID: 8763412
[TBL] [Abstract][Full Text] [Related]
16. Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability.
Prasad A; Andrews NP; Padder FA; Husain M; Quyyumi AA
J Am Coll Cardiol; 1999 Aug; 34(2):507-14. PubMed ID: 10440166
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.
Münzel T; Li H; Mollnau H; Hink U; Matheis E; Hartmann M; Oelze M; Skatchkov M; Warnholtz A; Duncker L; Meinertz T; Förstermann U
Circ Res; 2000 Jan; 86(1):E7-E12. PubMed ID: 10625313
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-199a-5p influences pulmonary artery hypertension via downregulating Smad3.
Liu Y; Liu G; Zhang H; Wang J
Biochem Biophys Res Commun; 2016 May; 473(4):859-866. PubMed ID: 27038547
[TBL] [Abstract][Full Text] [Related]
20. Elevated luteinizing hormone contributes to atherosclerosis formation by inhibiting nitric oxide synthesis via PI3K/Akt pathway.
Meng X; Li X; Xu X; Li P; Chen Y; Fu X; Xu X
Vascul Pharmacol; 2019 Oct; 121():106582. PubMed ID: 31437529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
